Does TOFACITINIB Cause Malignant melanoma? 166 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 166 reports of Malignant melanoma have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
166
Reports of Malignant melanoma with TOFACITINIB
0.1%
of all TOFACITINIB reports
10
Deaths
21
Hospitalizations
How Dangerous Is Malignant melanoma From TOFACITINIB?
Of the 166 reports, 10 (6.0%) resulted in death, 21 (12.7%) required hospitalization, and 5 (3.0%) were considered life-threatening.
Is Malignant melanoma Listed in the Official Label?
Yes, Malignant melanoma is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Malignant melanoma?
SILDENAFIL (1,248)
ADALIMUMAB (795)
TADALAFIL (741)
ETANERCEPT (495)
INFLIXIMAB (478)
METHOTREXATE (475)
DABRAFENIB (402)
LENALIDOMIDE (378)
RANITIDINE (352)
RITUXIMAB (291)
Which TOFACITINIB Alternatives Have Lower Malignant melanoma Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN